These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 36055981)
61. C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway. Xu D; Li M; Ran L; Li X; Sun X; Yin T Clin Transl Oncol; 2023 Feb; 25(2):440-446. PubMed ID: 36192575 [TBL] [Abstract][Full Text] [Related]
62. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061 [TBL] [Abstract][Full Text] [Related]
63. SNTB1 regulates colorectal cancer cell proliferation and metastasis through YAP1 and the WNT/β-catenin pathway. Zhang H; Li Z; Jiang J; Lei Y; Xie J; Liu Y; Yi B Cell Cycle; 2023 Sep; 22(17):1865-1883. PubMed ID: 37592763 [TBL] [Abstract][Full Text] [Related]
64. TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway. Chen J; Wang D; Chen H; Gu J; Jiang X; Han F; Cao J; Liu W; Liu J J Cancer Res Clin Oncol; 2023 Feb; 149(2):653-667. PubMed ID: 36355209 [TBL] [Abstract][Full Text] [Related]
65. Circular RNA circ_0068464 combined with microRNA-383 regulates Wnt/β-catenin pathway to promote the progression of colorectal cancer. Zou Y; Liu L; Meng J; Dai M Bioengineered; 2022 Mar; 13(3):5113-5125. PubMed ID: 35168468 [TBL] [Abstract][Full Text] [Related]
66. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling. Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794 [TBL] [Abstract][Full Text] [Related]
67. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway. Sun J; Zhang T; Cheng M; Hong L; Zhang C; Xie M; Sun P; Fan R; Wang Z; Wang L; Zhong J J Exp Clin Cancer Res; 2019 Feb; 38(1):104. PubMed ID: 30813948 [TBL] [Abstract][Full Text] [Related]
68. A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT. Kang AR; Kim JL; Kim Y; Kang S; Oh SC; Park JK Cancer Gene Ther; 2023 Oct; 30(10):1403-1413. PubMed ID: 37500894 [TBL] [Abstract][Full Text] [Related]
69. The RP11-417E7.1/THBS2 signaling pathway promotes colorectal cancer metastasis by activating the Wnt/β-catenin pathway and facilitating exosome-mediated M2 macrophage polarization. Liu Y; Lv H; Liu X; Xu L; Li T; Zhou H; Zhu H; Hao C; Lin C; Zhang Y J Exp Clin Cancer Res; 2024 Jul; 43(1):195. PubMed ID: 39020380 [TBL] [Abstract][Full Text] [Related]
70. TP53INP2 modulates the malignant progression of colorectal cancer by reducing the inactive form of β-catenin. Shi K; Shan Y; Sun X; Chen K; Luo Q; Xu Q Biochem Biophys Res Commun; 2024 Jan; 690():149275. PubMed ID: 37995453 [TBL] [Abstract][Full Text] [Related]
71. Hypoxia induced β-catenin lactylation promotes the cell proliferation and stemness of colorectal cancer through the wnt signaling pathway. Miao Z; Zhao X; Liu X Exp Cell Res; 2023 Jan; 422(1):113439. PubMed ID: 36464122 [TBL] [Abstract][Full Text] [Related]
72. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer. Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229 [TBL] [Abstract][Full Text] [Related]
73. MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling. Chen X; Tu J; Liu C; Wang L; Yuan X Life Sci; 2022 Nov; 308():120941. PubMed ID: 36087740 [TBL] [Abstract][Full Text] [Related]
74. BCAP31 is involved in modulating colorectal cancer cell proliferation via the Emerin/β-catenin axis. Han L; Shi J; Zhao L; Deng J; Li Y; Zhao H; Wang H; Yan Y; Zou F Exp Cell Res; 2022 Sep; 418(1):113265. PubMed ID: 35716785 [TBL] [Abstract][Full Text] [Related]
75. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769 [TBL] [Abstract][Full Text] [Related]
76. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis. Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601 [TBL] [Abstract][Full Text] [Related]
77. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986 [TBL] [Abstract][Full Text] [Related]
78. Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis. Jiang S; Li Q; Liu Y; Zhang H; Wang Q; Chen Y; Shi X; Li J; Zhang H; Zhang Y; Xia D; Wu M; Lin J; Zhang C; Pang S; Jiang J; Wen Y; Zhang P BMC Cancer; 2021 Feb; 21(1):180. PubMed ID: 33607955 [TBL] [Abstract][Full Text] [Related]
79. LINC01315 accelerates the growth and epithelial-mesenchymal transition of colorectal cancer cells via activating the Wnt/β-catenin signal. Liu Y; Zhou WL Bioengineered; 2022 Apr; 13(4):8396-8406. PubMed ID: 35322763 [TBL] [Abstract][Full Text] [Related]
80. GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells. Wu Z; Zhou S; Liang D; Mu L Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1115-1125. PubMed ID: 37610461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]